What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE
Sponsor
Rennes University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03668184
Collaborator
(none)
157
2
20.9
78.5
3.8
Study Details
Study Description
Brief Summary
The main goal is to determine which risk factors develop preeclampsia in this specific group of oocyte recipients.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
157 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE
Actual Study Start Date
:
Jan 2, 2018
Anticipated Primary Completion Date
:
Jul 1, 2019
Anticipated Study Completion Date
:
Oct 1, 2019
Outcome Measures
Primary Outcome Measures
- occurrence of pre-eclampsia [through study completion, an average of 1 year]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
Female
Inclusion Criteria:
- All major patients with a pregnancy of more than 22 weeks of amenorrhea resulting from an oocyte donation in one of the study centers, having given birth between January 2010 and April 2017 and not opposed to participation in the study.
Exclusion Criteria:
- all pregnancies resulting from an oocyte donation abroad, persons of legal age subject to legal protection (safeguard of justice, guardianship, tutorship) and persons deprived of their liberty.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHU de Rennes | Rennes | France | 35033 | |
| 2 | Clinique de la sagesse | Rennes | France | 35043 |
Sponsors and Collaborators
- Rennes University Hospital
Investigators
- Principal Investigator: Solène DUROS, MD, Rennes University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Rennes University Hospital
ClinicalTrials.gov Identifier:
NCT03668184
Other Study ID Numbers:
- 35RC17_3078_PREROVE
First Posted:
Sep 12, 2018
Last Update Posted:
Dec 19, 2018
Last Verified:
Sep 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: